We are upgrading the repository! A content freeze is in effect until December 6, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.

Show simple item record

dc.contributor.authorTanaka, Nobuyuki
dc.contributor.authorKamanaka, Masahito
dc.contributor.authorEnslen, Herve
dc.contributor.authorDong, Chen
dc.contributor.authorWysk, Mark Allen
dc.contributor.authorDavis, Roger J.
dc.contributor.authorFlavell, Richard A.
dc.date2022-08-11T08:08:49.000
dc.date.accessioned2022-08-23T16:09:20Z
dc.date.available2022-08-23T16:09:20Z
dc.date.issued2002-08-02
dc.date.submitted2009-01-13
dc.identifier.citationEMBO Rep. 2002 Aug;3(8):785-91. Epub 2002 Jul 15. <a href="http://dx.doi.org/10.1093/embo-reports/kvf153">Link to article on publisher's site</a>
dc.identifier.issn1469-221X (Print)
dc.identifier.doi10.1093/embo-reports/kvf153
dc.identifier.pmid12151339
dc.identifier.urihttp://hdl.handle.net/20.500.14038/32667
dc.description.abstractThe p38 mitogen-activated protein kinase (p38MAPK) is activated in response to various stimuli, including cellular stress, inflammatory cytokines and cell surface receptors. The activation of p38MAPK is predominantly mediated by the two upstream MAPK kinases MKK3 and MKK6. To study the role of the p38MAPK pathway in vivo, we generated Mkk6-/- mice. We examined whether T-cell apoptosis is affected in these mice and in our previously reported Mkk3-/- mice. Strikingly, in vivo deletion of double positive thymocytes in Mkk6-/- mice was impaired, whereas Mkk3-/- mice showed no apparent abnormality. Conversely, CD4(+)T cells from Mkk3-/- but not from Mkk6-/- mice were resistant to activation-induced cell death and cytokine-withdrawal-induced apoptosis. In peripheral CD4(+)T cells, MKK3 is induced upon stimulation, whereas MKK6 is downregulated. These results suggest a novel mechanism regulating T-cell apoptosis differentially through the p38MAPK pathway by MKK3 and MKK6.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=12151339&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1093/embo-reports/kvf153
dc.titleDifferential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis
dc.typeJournal Article
dc.source.journaltitleEMBO reports
dc.source.volume3
dc.source.issue8
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/1227
dc.identifier.contextkey693137
html.description.abstract<p>The p38 mitogen-activated protein kinase (p38MAPK) is activated in response to various stimuli, including cellular stress, inflammatory cytokines and cell surface receptors. The activation of p38MAPK is predominantly mediated by the two upstream MAPK kinases MKK3 and MKK6. To study the role of the p38MAPK pathway in vivo, we generated Mkk6-/- mice. We examined whether T-cell apoptosis is affected in these mice and in our previously reported Mkk3-/- mice. Strikingly, in vivo deletion of double positive thymocytes in Mkk6-/- mice was impaired, whereas Mkk3-/- mice showed no apparent abnormality. Conversely, CD4(+)T cells from Mkk3-/- but not from Mkk6-/- mice were resistant to activation-induced cell death and cytokine-withdrawal-induced apoptosis. In peripheral CD4(+)T cells, MKK3 is induced upon stimulation, whereas MKK6 is downregulated. These results suggest a novel mechanism regulating T-cell apoptosis differentially through the p38MAPK pathway by MKK3 and MKK6.</p>
dc.identifier.submissionpathgsbs_sp/1227
dc.contributor.departmentProgram in Molecular Medicine
dc.contributor.departmentMorningside Graduate School of Biomedical Sciences
dc.source.pages785-91


This item appears in the following Collection(s)

Show simple item record